Most importantly, tumours might escape immunosurveillance by activating checkpoint blockades by the expression of PD1, PD-L1, CTLA4 and others by tumour cells and immune cells to prevent the activation of cytotoxic T cells for tumour cell killing. The gene discussed is CTLA4; the disease is neoplasm.